A Study of B + L Ophthalmic Viscosurgical Device (OVD) CVisc50
A Study to Document the Safety and Effectiveness of a New Cohesive OVD When Compared to a Control OVD
Sponsor: Bausch & Lomb Incorporated
A NA clinical study on Cataract, this trial is completed. The trial is conducted by Bausch & Lomb Incorporated and has accumulated 13 data snapshots since 2019. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
13 versions recorded-
Sep 2025 — Present [monthly]
Completed NA
-
Sep 2024 — Sep 2025 [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jun 2024 — Jul 2024 [monthly]
Completed NA
-
Jan 2023 — Jun 2024 [monthly]
Completed NA
▶ Show 8 earlier versions
-
Sep 2022 — Jan 2023 [monthly]
Completed NA
-
Jul 2022 — Sep 2022 [monthly]
Completed NA
-
Apr 2022 — Jul 2022 [monthly]
Completed NA
Status: Recruiting → Completed
-
Dec 2021 — Apr 2022 [monthly]
Recruiting NA
-
Sep 2021 — Dec 2021 [monthly]
Recruiting NA
Status: Withheld → Recruiting · Phase: None → NA
-
Jun 2021 — Sep 2021 [monthly]
Withheld
-
Jan 2021 — Jun 2021 [monthly]
Withheld
-
Jan 2020 — Jan 2021 [monthly]
Withheld
First recorded
Nov 2019
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Bausch & Lomb Incorporated
For direct contact, visit the study record on ClinicalTrials.gov .